Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Conjunctival melanoma is a rare primary ocular tumor. So far, no standard treatment exists for metastatic disease. Similarly to cutaneous melanoma, up to 50% of conjunctival melanomas harbor BRAF mutations. The most common is represented by V600E. Combined therapy with BRAF and MEK inhibitors is app...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Rossi, Ernesto, Maiorano, Brigida Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Dosa, Tommaso, Martini, Maurizio, Rindi, Guido, Bria, Emilio, Blasi, Maria Antonietta, Tortora, Giampaolo, Schinzari, Giovanni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6460374/
https://ncbi.nlm.nih.gov/pubmed/31024839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00232
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak